In this interview with Chad Rose, General Manager of hēRo3, he explains how biopharma is incorporating critical HEOR insights into decision-making for early pipeline assets. Why is there a need to revolutionize the way HEOR insights are used in the… Continue Reading
The ever-expanding field of pharmacovigilance highlights the importance of identifying and tackling problems with real-world safety reporting. Despite this drive to improve healthcare, overtaxed healthcare providers face a current real-world safety reporting process that is too burdensome. For example, researchers… Continue Reading
Barely a day goes by without a headline touting how some new generative AI system will transform our lives by detecting cancer, expediting diagnosis, or helping doctors provide better care. But I’d bet my house that none of these claims… Continue Reading
This podcast segment features the Q&A from Magnolia Market Access’ April 6, 2023 webinar with HealthEconomics.Com. In this episode of tHEORetically speaking, join Dr. Pamela Landsman-Blumberg from Magnolia Market Access and Dr. Rick Chapman from Innovation and Value Initiatives as… Continue Reading
Precision medicine and value-based care are buzzwords used over the last two decades. At inception, these principles were seen as two opposing forces in the fight against cancer. Now, industry leaders view precision medicine and value-based care as two sides… Continue Reading
